IOVA Financials
Iovance Biotherapeutics Inc - Financial statements & key metrics
Stock Price
$3.64
Market Cap
$1.43B
EPS
$-1.09
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$164.07M
Gross Profit
-
Operating Income
-
Net Income
$-372.18M
EPS (Diluted)
$-1.28
Balance Sheet Highlights
Total Assets
$910.43M
Total Liabilities
$200.02M
Shareholders Equity
-
Cash & Equivalents
$115.69M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-352.98M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
34.3%
Operating Margin
-0.8%
Net Margin
-1.5%
ROE
-0.6%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is IOVA revenue?
IOVA's most recent quarterly revenue was $164.07M. Annual revenue can be calculated by summing the four most recent quarters.
Is IOVA profitable?
IOVA reported a loss of $372.18M in the most recent quarter. The net profit margin is -1.5%.
What is IOVA market cap?
IOVA has a market capitalization of $1.43B, making it a small-cap stock.
Does IOVA have debt?
View IOVA's balance sheet for debt information.
What is IOVA cash flow?
Cash flow data is available in the full financial statements.